Bridgeway Capital Management’s Lyra Therapeutics LYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,736
| Closed | -$540K | – | 1313 |
|
|
2024
Q1 | $540K | Sell |
1,736
-1,100
| -39% | -$342K | 0.01% | 905 |
|
|
2023
Q4 | $743K | Hold |
2,836
| – | – | 0.02% | 833 |
|
|
2023
Q3 | $554K | Buy |
2,836
+900
| +46% | +$176K | 0.01% | 850 |
|
|
2023
Q2 | $398K | Sell |
1,936
-1,000
| -34% | -$206K | 0.01% | 969 |
|
|
2023
Q1 | $304K | Hold |
2,936
| – | – | 0.01% | 1004 |
|
|
2022
Q4 | $461K | Buy |
2,936
+1,798
| +158% | +$282K | 0.01% | 899 |
|
|
2022
Q3 | $285K | Hold |
1,138
| – | – | 0.01% | 1058 |
|
|
2022
Q2 | $321K | Sell |
1,138
-200
| -15% | -$56.4K | 0.01% | 983 |
|
|
2022
Q1 | $269K | Hold |
1,338
| – | – | 0.01% | 1109 |
|
|
2021
Q4 | $292K | Sell |
1,338
-40
| -3% | -$8.73K | 0.01% | 1106 |
|
|
2021
Q3 | $630K | Buy |
1,378
+540
| +64% | +$247K | 0.01% | 967 |
|
|
2021
Q2 | $336K | Sell |
838
-142
| -14% | -$56.9K | 0.01% | 1185 |
|
|
2021
Q1 | $568K | Hold |
980
| – | – | 0.01% | 1056 |
|
|
2020
Q4 | $559K | Buy |
+980
| New | +$559K | 0.01% | 906 |
|